- Home
- BMRN vs REGCO Comparison
BMRN vs REGCO Comparison
Compare BMRN & REGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- REGCO
- Stock Information
- Founded
- BMRN 1996
- REGCO N/A
- Country
- BMRN United States
- REGCO United States
- Employees
- BMRN N/A
- REGCO 500
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- REGCO
- Sector
- BMRN Health Care
- REGCO
- Exchange
- BMRN Nasdaq
- REGCO Nasdaq
- Market Cap
- BMRN 13.7B
- REGCO N/A
- IPO Year
- BMRN 1999
- REGCO N/A
- Fundamental
- Price
- BMRN $70.52
- REGCO $22.32
- Analyst Decision
- BMRN Buy
- REGCO
- Analyst Count
- BMRN 22
- REGCO 0
- Target Price
- BMRN $94.00
- REGCO N/A
- AVG Volume (30 Days)
- BMRN 1.6M
- REGCO N/A
- Earning Date
- BMRN 04-23-2025
- REGCO N/A
- Dividend Yield
- BMRN N/A
- REGCO N/A
- EPS Growth
- BMRN 153.71
- REGCO N/A
- EPS
- BMRN 2.21
- REGCO N/A
- Revenue
- BMRN $2,853,915,000.00
- REGCO N/A
- Revenue This Year
- BMRN $12.23
- REGCO N/A
- Revenue Next Year
- BMRN $9.90
- REGCO N/A
- P/E Ratio
- BMRN $31.97
- REGCO N/A
- Revenue Growth
- BMRN 17.97
- REGCO N/A
- 52 Week Low
- BMRN $60.63
- REGCO N/A
- 52 Week High
- BMRN $94.85
- REGCO N/A
- Technical
- Relative Strength Index (RSI)
- BMRN 59.12
- REGCO 46.59
- Support Level
- BMRN $69.89
- REGCO $22.30
- Resistance Level
- BMRN $73.51
- REGCO $22.84
- Average True Range (ATR)
- BMRN 2.04
- REGCO 0.12
- MACD
- BMRN 0.16
- REGCO -0.02
- Stochastic Oscillator
- BMRN 52.81
- REGCO 13.63
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About REGCO Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.